Corteva, Inc. $CTVA Holdings Lowered by Van ECK Associates Corp

Van ECK Associates Corp cut its stake in Corteva, Inc. (NYSE:CTVA) by 62.6% in the 3rd quarter, HoldingsChannel reports. The fund owned 1,808,962 shares of the company’s stock after selling 3,024,639 shares during the period. Van ECK Associates Corp’s holdings in Corteva were worth $122,340,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Activest Wealth Management boosted its stake in Corteva by 118.3% during the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after purchasing an additional 200 shares in the last quarter. True Wealth Design LLC boosted its stake in Corteva by 209.5% during the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after buying an additional 264 shares in the last quarter. Total Investment Management Inc. bought a new position in shares of Corteva during the 2nd quarter valued at about $27,000. Twin Peaks Wealth Advisors LLC bought a new stake in Corteva during the second quarter worth approximately $29,000. Finally, Redmont Wealth Advisors LLC acquired a new stake in shares of Corteva during the 3rd quarter valued at $29,000. Institutional investors own 81.54% of the company’s stock.

Insider Buying and Selling at Corteva

In other Corteva news, insider Brian Titus sold 8,311 shares of the company’s stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the transaction, the insider owned 8,090 shares of the company’s stock, valued at $619,289.50. This represents a 50.67% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 0.15% of the company’s stock.

Corteva Trading Down 2.6%

Shares of NYSE:CTVA opened at $76.30 on Wednesday. The firm has a market cap of $51.31 billion, a price-to-earnings ratio of 48.29, a PEG ratio of 2.68 and a beta of 0.72. The company’s fifty day simple moving average is $73.40 and its 200 day simple moving average is $69.06. Corteva, Inc. has a 12 month low of $53.40 and a 12 month high of $80.90. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting the consensus estimate of $0.22. The company had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.Corteva’s revenue for the quarter was down 1.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, research analysts forecast that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be issued a $0.18 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio is 45.57%.

Analyst Upgrades and Downgrades

CTVA has been the subject of a number of recent analyst reports. Rothschild & Co Redburn decreased their price objective on shares of Corteva from $71.00 to $65.00 and set a “neutral” rating for the company in a research note on Tuesday, November 11th. Wells Fargo & Company upped their price target on Corteva from $77.00 to $85.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Zacks Research downgraded Corteva from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 20th. Citigroup boosted their price target on Corteva from $74.00 to $80.00 and gave the company a “neutral” rating in a research note on Thursday, February 5th. Finally, Royal Bank Of Canada raised their price target on shares of Corteva from $80.00 to $89.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. One analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $82.90.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.